• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.25
  • VXN 17.82
  • VXO 15.25
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





Company Profile

QIAGEN N.V., through its subsidiaries, provides sample and assay technologies. Sample technologies are used to isolate and process deoxyribonucleic acid, ribonucleic acid, and proteins from biological samples, such as blood or tissue; and assay technologies are used to make such isolated bio-molecules visible. It markets approximately 500 sample and assay products, as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes, such as forensics, animal or food testing, and pharmaceutical process control. QIAGEN's primary assay technologies include the broadest panels of molecular diagnostic tests available. This panel comprises the digene HPV Test, which is regarded as a ?gold standard? in testing for high-risk types of human papillomavirus, the primary cause of cervical cancer, as well as a broad suite of solutions for infectious disease testing and companion diagnostics. The company markets its products through a sales force and a network of distributors principally in the Americas, Germany, Asia, and Switzerland. It has a collaboration agreement with Genome Diagnostics B.V. for development of tests for applications in prevention and personalized healthcare. QIAGEN was founded in 1986 and is headquartered in Venlo, the Netherlands.

NO
     
QGEN (Qiagen NV)
Last Trade 28.49 Date 10/18/2019
Change % 1.10 % Price Change 0.31
Open 28.36 52 Week High 41.55
High 28.64 52 Week Low 25.04
Low 28.29 Type stock
Volume 2132442 Average Volume 1283988
Prev Close 28.18 Stock Exchange NYSE
Bid 23.0 Ask 31.0
Bid Size 1 Ask Size 27
1st Yr Estimated EPS Growth 0.8196 2nd Yr Estimated EPS Growth 0.0553
2 Years Forward Earning Yield 0.0566 2 Years Forward PE Ratio 17.6627
2 Years EV/Forward EBIT 15.5084 2 Years EV/Forward EBITDA 12.4807
Book Value per Share 11.6236 Book Value Yield 0.408
Buy Back Yield 0.0238 CAPE Ratio 52.0055
Cash Return 0.0137 Cash Flow per Share 1.3727
Cash Flow Yield 0.0482 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield 0.0295 EV/EBIT 25.1049
EV/EBITDA 14.3881 EV / Free Cash Flow 157.0034
EV / Forward EBIT 19.9556 EV / Forward EBITDA 14.2474
EV / Forward Revenue 4.5155 EV / Pre Tax Income 33.6339
EV / Revenue 4.9164 EV / Total Asset 1.3805
Expected Dividend Growth Rate Free Cash Flow per Share 0.2027
Free Caash Flow Ratio 140.539871 Free Cash Flow Yield 0.0071
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield 0.0537 Forward PE Ratio 18.622
Forward Return on Asset 0.0643 Forward Return on Equity 0.1315
Normalized PE Ratio 33.916667 Payout Ratio 0.0
PB Ratio 2.451053 PB Ratio 10 Year Growth 0.008652
PB Ratio 3 Year Growth 3.00365 Cash Ratio 3 Year Average 1125.4138
Price to Cash Flow Ratio 20.754226 PEG Payback 9.9123
PEG Ratio 1.8009 PE Ratio 33.916667
PE Ratio 10 Year Average 62.101326 PE Ratio 10 Year Growth -0.009674
PE Ratio 10 Year High 203.470588 PE Ratio 10 Year Low 22.999993
PE Ratio 1 Year Avg 59.404604 PE Ratio 1 Year High 108.818182
PE Ratio 1 Year Low 30.25 PE Ratio 3 Year Avg 92.0041
PE Ratio 5 Year Avg 75.065019 PE Ratio 5 Year High 203.470588
PE Ratio 5 Year Low 30.25 Free Cash Flow Ratio 10 Year Growth 0.191408
Free Cash Flow Ratio 3 Year Avg 53.867589 Price Change 1 Month 0.864119
Price to Cash Ratio 8.209235 Price / EBITDA 12.87932
Price to Sales Ratio 4.400827 Price to Sales Ratio 10 Year Growth -0.004945
Price to Sales Ratio 3 Year Avg 5.508039 Price to Sales Ratio 5 Year Avg 75.065019
Sale per Share 6.4738 Sales Yield 0.2272
Sustainable Growth Rate 0.0758 Tangible Book Value per Share -0.7322
Tangible Book Value per Share 3 year Avg 0.0255 Tangible Book Value per Share 5 year Avg 0.1971
Total Asset per Share 23.7672 Total Yield 0.0238
Working Capital per Share 3.1107 Working Capital per Share 3 Year Avg 3.67
Working Capital per Share 5 Year Avg 3.5698 Beta 0.745757
12